
	Vansen Pharma Inc. is a specialty pharmaceutical company focused on broad therapeutic areas that are anticipated to grow and present an opportunity for major expansion.&nbsp; Vansen will expand its commercial presence by adding complimentary products through in-licensing, co-promotion and acquisitions, resulting in a comprehensive product portfolio.&nbsp; With its US based sales force, Vansen can better serve the increasing healthcare needs of patients and enhance growth.&nbsp; Vansen&#39;s current product portfolio of anti-infectives, including Factive&reg;, Spectracef&reg; and Cefditoren Pivoxil&reg;, provides a strong and stable revenue base from which to grow and expand our company. Our experienced management team is aggressively pursuing acquisitions of accretive specialty products, including legacy drugs and cash flow positive healthcare companies.&nbsp; We look forward to executing our growth strategy and creating lasting shareholder value for our investors.
